Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease [Phase 3]
Phase 3 clinical trial evaluating off-label ocrelizumab versus rituximab at onset of relapsing-remitting multiple sclerosis; currently activ…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis
A clinical trial is evaluating the effectiveness of combining a disease-modifying therapy with the Yishen Daluo Yin Modified Formula for rel…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial update evaluating the impact of cladribine tablets on central nervous system biomarkers in individuals with multiple …
-
CLINICAL_TRIALS research · 2025-06-02Clinical Trial Update: Cladribine Tablets as an Exit Therapy Strategy
A clinical trial is evaluating cladribine tablets as an exit therapy strategy for multiple sclerosis, including relapsing-remitting and seco…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
An ongoing IOBA-sponsored study is evaluating visual processing speed and objective ocular movement analysis in individuals with Multiple Sc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC [NA]
The MultiSCRIPT-Cycle 1 study is a pragmatic platform trial embedded within the SMSC aimed at personalized medicine approaches for Relapsing…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) [NA]
A completed clinical trial (RETIMUS) investigating the detection of retinal perivascular inflammation in multiple sclerosis patients using a…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration [Phase 2]
Phase 2 clinical trial evaluating intranasal methylprednisolone for acute relapses in Relapsing-Remitting Multiple Sclerosis. The study is c…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis [Phase 1]
This update describes a Phase 1 study evaluating allogeneic hematopoietic cell transplantation for primary progressive multiple sclerosis, w…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Serum Neurofilament Light in Multiple Sclerosis
This entry notes an ongoing study of serum neurofilament light in multiple sclerosis, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Multiple Sclerosis and the Effects of Ketogenic Diet Therapy [NA]
A clinical trial is evaluating ketogenic diet therapy for people with relapsing-remitting multiple sclerosis; the study is currently recruit…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Deuterium Metabolic Imaging in People with Multiple Sclerosis
A clinical trial update indicates a study on deuterium metabolic imaging in people with relapsing-remitting multiple sclerosis is currently …
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Calorie Restriction in Multiple Sclerosis [NA]
A clinical trial is investigating caloric restriction as a potential intervention for Relapsing-Remitting Multiple Sclerosis, with status li…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
This trial update describes the development of a camera-based gait quality measure for people with multiple sclerosis and notes that recruit…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants
Biogen's Canadian multicenter observational study of natalizumab (Tysabri) in patients with early Relapsing-Remitting Multiple Sclerosis has…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy, pharmacokinetics, pharmacodynamics, and safety of CT-P53 versus Ocrevus in relapsing-re…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis [NA]
A clinical trial is evaluating whether adding conjugated linoleic acid and the probiotic Vivomixx to first-line immunotherapy improves outco…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating the effects of ocrelizumab on immune responses in participants with relapsing forms of multiple sclerosis has compl…
-
CLINICAL_TRIALS research · 2018-04-13Clinical Trial Update: Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis [NA]
This clinical trial update describes a study evaluating whether task-oriented training improves functional mobility and reduces fatigue in R…
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients [Phase 4]
Phase 4 clinical trial update examining indirect neuroprotective effects of Tecfidera (dimethyl fumarate) in relapsing-remitting and progres…
-
CLINICAL_TRIALS research · 2018-01-12Clinical Trial Update: Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. [Phase 4]
A Phase 4 clinical trial evaluating patient retention of fingolimod compared with currently approved disease-modifying therapies in relapsin…
-
CLINICAL_TRIALS research · 2017-10-25Clinical Trial Update: Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition
A completed clinical trial update reports on participants' preferences among disease-modifying therapies for relapsing-remitting multiple sc…
-
CLINICAL_TRIALS research · 2017-10-12Clinical Trial Update: Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis [Phase 2]
Endpoint calibration update for a Phase 2 study of lisinopril in relapsing-remitting multiple sclerosis. The update is associated with Trans…
-
CLINICAL_TRIALS research · 2017-05-15Clinical Trial Update: An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab [Phase 3]
A clinical trial update describes an extension protocol for patients with relapsing-remitting multiple sclerosis who previously participated…
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)
An observational study completed to characterize real-world clinical outcomes in relapsing-remitting multiple sclerosis.